BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9655 related articles for article (PubMed ID: 1314533)

  • 1. Combined effects of lonidamine and hyperthermia on malignant melanoma and lung carcinoma surgical specimens.
    Zaffaroni N; Villa R; Orlandi L; Vaglini M; Silvestrini R
    Anticancer Res; 1992; 12(1):247-50. PubMed ID: 1314533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA synthesis by lonidamine and hyperthermia in human chronic myeloid leukemia cells.
    Chitnis M; Juvekar A; Adwankar M; Advani S
    Anticancer Res; 1986; 6(4):749-51. PubMed ID: 3463243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanoma.
    Zaffaroni N; Villa R; Daidone MG; Vaglini M; Santinami M; Silvestrini R
    Int J Cell Cloning; 1989 Nov; 7(6):385-94. PubMed ID: 2809274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro effects of lonidamine combined with cisplatin in human small cell lung cancer cell lines.
    Ko D; Raaphorst GP; Feeley MM; Danjoux CE; Maroun JA; Evans WK
    Anticancer Res; 1991; 11(1):235-9. PubMed ID: 1850216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal behavior of a human glioma cell line and its response to combinations of hyperthermia and lonidamine.
    Floridi A; Gentile FP; Bruno T; Delpino A; Iacobini C; Paggi MG; Castiglione S; Benassi M
    Oncol Res; 1993; 5(1):1-10. PubMed ID: 8369571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human bone marrow progenitors (CFU-C) and human clonogenic tumor cells implanted into mice.
    Neumann HA; Fiebig HH; Löhr GW; Engelhardt R
    J Natl Cancer Inst; 1985 Dec; 75(6):1059-66. PubMed ID: 2999496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.
    Adwankar MK; Chitnis MP
    Neoplasma; 1986; 33(2):217-23. PubMed ID: 3713924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of cisplatin cytotoxicity by lonidamine in primary cultures of human ovarian cancer.
    Orlandi L; Zaffaroni N; Gornati D; Veneroni S; Silvestrini R
    Anticancer Res; 1994; 14(3A):1161-4. PubMed ID: 8074467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of lonidamine alone and in combination with cisplatin on in vitro growth and viability of lung squamous cell carcinoma cell lines.
    Raaphorst GP; Ko D; Feeley MM; Danjoux CE; Maroun J; Evans WK
    Anticancer Res; 1991; 11(1):41-7. PubMed ID: 2018379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines.
    Goss P; Parsons PG
    Cancer Res; 1977 Jan; 37(1):152-6. PubMed ID: 830403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
    Kiura K; Ohnoshi T; Ueoka H; Takigawa N; Tabata M; Segawa Y; Shibayama T; Kimura I
    Anticancer Drug Des; 1992 Dec; 7(6):463-70. PubMed ID: 1337430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of thermosensitivity by amrubicin or amrubicinol in human lung adenocarcinoma A549 cells and the kinetics of apoptosis and necrosis induction.
    Hayashi S; Hatashita M; Matsumoto H; Jin ZH; Shioura H; Kano E
    Int J Mol Med; 2005 Sep; 16(3):381-7. PubMed ID: 16077943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo cytotoxicity of rhodamine 123 combined with hyperthermia.
    Goffney WH; Wong JH; Kern DH; Chase D; Krag DN; Storm FK
    Cancer Res; 1990 Feb; 50(3):459-63. PubMed ID: 2297690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E
    Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative.
    Hollingshead M; Alley M; Burger AM; Borgel S; Pacula-Cox C; Fiebig HH; Sausville EA
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):115-25. PubMed ID: 15791458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of radiation response of prostatic carcinoma by lonidamine.
    Dudak SD; Lopez A; Block NL; Lokeshwar BL
    Anticancer Res; 1996; 16(6B):3665-71. PubMed ID: 9042239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect by proliferation kinetics of malignant tumors of children of hyperthermia].
    Willnow U
    Acta Histochem Suppl; 1990; 39():189-94. PubMed ID: 1964233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperthermia on combination interferon treatment: enhancement of the antiproliferative activity against murine B-16 melanoma.
    Fleischmann WR; Fleischmann CM; Gindhart TD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1722-6. PubMed ID: 3081255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 483.